Literature DB >> 2464601

Structure of a collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes.

S T Boyce1, D J Christianson, J F Hansbrough.   

Abstract

Collagen and glycosaminoglycan (GAG) dermal skin substitutes (membranes) were studied as substrates for cultured human epidermal keratinocytes. Structure of dermal substitutes was optimized for pore size to promote ingrowth of fibrovascular tissue from the wound bed and for culture of human keratinocytes of the membrane's surface. Pore size of the freeze-dried material was regulated by control of the temperature of freezing between -50 degrees C and -20 degrees C and by concentration of starting materials between 0.17% and 1.62% wt/vol. A nonporous surface of collagen-GAG was laminated to the membranes to provide a planar substrate for cultured epidermal keratinocytes. Thickness of dermal substitutes was regulated by control of the volume and concentration of starting materials. Biotin was conjugated to solubilized collagen for binding with avidin of specific quantities of biologically active molecules. The optimized membranes are suitable substrates for the culture of human epidermal keratinocytes, and together with the cells yield a composite material that is histologically similar to skin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2464601     DOI: 10.1002/jbm.820221008

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  29 in total

Review 1.  Applications of reconstructed skin models in pharmaco-toxicological trials.

Authors:  O Damour; C Augustin; A F Black
Journal:  Med Biol Eng Comput       Date:  1998-11       Impact factor: 2.602

Review 2.  Tissue engineering of the vascular system: from capillaries to larger blood vessels.

Authors:  L Germain; M Rémy-Zolghadri; F Auger
Journal:  Med Biol Eng Comput       Date:  2000-03       Impact factor: 2.602

3.  Comparative analysis of different collagen-based biomaterials as scaffolds for long-term culture of human fibroblasts.

Authors:  G Vaissiere; B Chevallay; D Herbage; O Damour
Journal:  Med Biol Eng Comput       Date:  2000-03       Impact factor: 2.602

4.  Cultured skin substitutes reduce donor skin harvesting for closure of excised, full-thickness burns.

Authors:  Steven T Boyce; Richard J Kagan; Kevin P Yakuboff; Nicholas A Meyer; Mary T Rieman; David G Greenhalgh; Glenn D Warden
Journal:  Ann Surg       Date:  2002-02       Impact factor: 12.969

5.  De novo synthesis of human dermis in vitro in the absence of a three-dimensional scaffold.

Authors:  Tara Pouyani; Vincent Ronfard; Paul G Scott; Carole M Dodd; Aftab Ahmed; Richard L Gallo; Nancy L Parenteau
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-06-16       Impact factor: 2.416

6.  Collagen-based biomaterials as 3D scaffold for cell cultures: applications for tissue engineering and gene therapy.

Authors:  B Chevallay; D Herbage
Journal:  Med Biol Eng Comput       Date:  2000-03       Impact factor: 2.602

Review 7.  Review collagen-based biomaterials for wound healing.

Authors:  Sayani Chattopadhyay; Ronald T Raines
Journal:  Biopolymers       Date:  2014-08       Impact factor: 2.505

8.  Randomized, Paired-Site Comparison of Autologous Engineered Skin Substitutes and Split-Thickness Skin Graft for Closure of Extensive, Full-Thickness Burns.

Authors:  Steven T Boyce; Peggy S Simpson; Mary T Rieman; Petra M Warner; Kevin P Yakuboff; J Kevin Bailey; Judith K Nelson; Laura A Fowler; Richard J Kagan
Journal:  J Burn Care Res       Date:  2017 Mar/Apr       Impact factor: 1.845

9.  Genomic Reprogramming and Skin-Like Maturation of Engineered Human Skin Substitutes.

Authors:  Dorothy M Supp
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-04       Impact factor: 4.730

10.  Barrier properties of an N/TERT-based human skin equivalent.

Authors:  Vincent van Drongelen; Mogbekeloluwa O Danso; Aat Mulder; Arnout Mieremet; Jeroen van Smeden; Joke A Bouwstra; Abdoelwaheb El Ghalbzouri
Journal:  Tissue Eng Part A       Date:  2014-08-04       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.